1. Enzyme inhibitors for drug discovery

   • Patrick Meffre
   • Zohra Benfodda
   • Sébastien Albrecht

   Editorial 28 November 2023 Pages: 1707 - 1708

2. In the quest for histone deacetylase inhibitors: current trends in the application of multilayered computational methods

   • Abdullahi Ibrahim Uba
   • Gokhan Zengin

   Original Article 27 June 2023 Pages: 1709 - 1726

   

3. Publisher’s Note: Phenolic compounds as histone deacetylase inhibitors: binding propensity and interaction insights from molecular docking and dynamics simulations

   Publisher Note 02 December 2023 Pages: 1727 - 1727

4. Phenolic compounds as potential adenosine deaminase inhibitors: molecular docking and dynamics simulation coupled with MM-GBSA calculations

   • Abdullahi Ibrahim Uba
   • Nicholas Joseph Paradis
   • Gokhan Zengin

   Original Article 30 July 2023 Pages: 1729 - 1743

   

5. CSC01 shows promise as a potential inhibitor of the oncogenic G13D mutant of KRAS: an in silico approach

   • Olanrewaju Ayodeji Durojaye
   • Umer Ejaz
   • Mukhtar Oluwaseun Idris

   Original Article 27 July 2023 Pages: 1745 - 1764

   

6. Sweroside: An iridoid glycoside of potential neuroprotective, antidiabetic, and antioxidant activities supported by molecular docking

   • Gokhan Zengin
   • Mohamed El-Raey
   • Omayma A. Eldahshan

   Original Article 20 March 2023 Pages: 1765 - 1774

   

7. Covalent-reversible peptide-based protease inhibitors. Design, synthesis, and clinical success stories

   • Anthony Feral
   • Anthony R. Martin
   • Lubomir L. Vezenkov

   Review Article 17 June 2023 Pages: 1775 - 1800

   

8. Publisher’s Note: Chromogranin A-derived peptides pancreastatin and catestatin: emerging therapeutic target for diabetes

   Publisher Note 30 November 2023 Pages: 1801 - 1801

9. Antineoplastic activity of plant-derived compounds mediated through inhibition of histone deacetylase: a review

   • N. Divya Rajaselvi
   • M. D. Jida
   • A. R. Nisha

   Review Article 30 June 2023 Pages: 1803 - 1817

   

10. Mucosal-associated invariant T cells display both pathogenic and protective roles in patients with inflammatory bowel diseases

    • Lei Wei
    • Zhigang Chen
    • Qiang Lv

    Review Article 11 October 2023 Pages: 1819 - 1827

    

11. Potential of milk-derived bioactive peptides as antidiabetic, antihypertensive, and xanthine oxidase inhibitors: a comprehensive bibliometric analysis and updated review

    • Emyr Hiago Bellaver
    • Aniela Pinto Kempka

    Review Article 08 November 2023 Pages: 1829 - 1855

    

12. Amino acid-stimulated insulin secretion: a path forward in type 2 diabetes

    • Jelena Kolic
    • WenQing Grace Sun
    • Nicola Guess

    Review Article 15 November 2023 Pages: 1857 - 1866

    

13. Binding of berberine to PEBP1 synergizes with sorafenib to induce the ferroptosis of hepatic stellate cells

    • Zhongping Xie
    • Yu Zhou
    • Caihua Huang

    Original Article 09 October 2023 Pages: 1867 - 1878

    

14. Serum albumin acted as an effective carrier to improve the stability of bioactive flavonoid

    • Ya-Di Yang
    • Naihao Lu
    • Rong Tian

    Original Article 19 October 2023 Pages: 1879 - 1890

    

15. Effect of lipopeptide extracted from Bacillus licheniformis on the expression of bap and luxI genes in multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa

    • Farangis Ghanipour
    • Razieh Nazari
    • Parvaneh Jafari

    Original Article 31 October 2023 Pages: 1891 - 1907

    

16. Exploring details about structure requirements based on antioxidant tripeptide derived from β-Lactoglobulin by in silico approaches

    • Fangfang Wang
    • Menghao Wen
    • Bo Zhou

    Original Article 02 November 2023 Pages: 1909 - 1922

    

17. Investigating molecular interactions between human transferrin and resveratrol through a unified experimental and computational approach: Role of natural compounds in Alzheimer’s disease therapeutics

    • Mohd Shahnawaz Khan
    • Mohammad Furkan
    • Anas Shamsi

    Original Article 05 November 2023 Pages: 1923 - 1935

    

18. Altered kynurenine pathway metabolism and association with disease activity in patients with systemic lupus

    • Duygu Eryavuz Onmaz
    • Dilek Tezcan
    • Ali Unlu

    Original Article 05 November 2023 Pages: 1937 - 1947

19. Safety assessment of L-Arg oral intake in healthy subjects: a systematic review of randomized control trials

    • Yui Kuramochi
    • Mai Murata
    • Kohsuke Hayamizu

    Original Article Open access 10 November 2023 Pages: 1949 - 1964

    

20. A novel antibacterial approach of Cecropin-B peptide loaded on chitosan nanoparticles against MDR Klebsiella pneumoniae isolates

    • Hend Okasha
    • Heba Dahroug
    • Mohamed Abbas Shemis

    Original Article Open access 15 November 2023 Pages: 1965 - 1980

    

21. Synthesis and glutathione peroxidase (GPx)-like activity of selenocystine (SeC) bioconjugates of biotin and lipoic acid

    • Shakti K. Maurya
    • Abhishek Tripathi
    • Harkesh B. Singh

    Original Article 16 November 2023 Pages: 1981 - 1989

    

22. Acetylcholine hydrolytic activity of fibrillated β-amyloid (1–40) peptide

    • Ivan Sanchis
    • Roque Spinelli
    • Alvaro Siano

    Brief Report 30 October 2023 Pages: 1991 - 1997